A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy

Authors

• Vivian Rismondo, Greater Baltimore Medical Center (GBMC)

Document Type

Article

Publication Title

Ophthalmology

First Page

62

Last Page

74

DOI

https://doi.org/10.1016/j.ophtha.2025.07.039

Publication Date

1-2026

Recommended Citation

Levin LA, Bhatti MT, Klier S, Morgenstern R, Szanto D, Miller NR, Kupersmith MJ; Quark NAION Study Group. A Randomized Sham-Controlled Phase 2/3 Trial of QPI-1007 for Acute Nonarteritic Anterior Ischemic Optic Neuropathy. Ophthalmology. 2026 Jan;133(1):62-74. doi: 10.1016/j.ophtha.2025.07.039. Epub 2025 Aug 14. PMID: 40816607.